Endocrinology

>

Latest News

FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes / Image credit: ©Argus/AdobeStock
FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes

December 23rd 2024

The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.

Crinecerfont for Congenital Adrenal Hyperplasia Now Commercially Available, Neurocrine Biosciences Announces / image credit courtesy of Neurocrine Biosciences
Crinecerfont for Congenital Adrenal Hyperplasia Now Commercially Available, Neurocrine Biosciences Announces

December 20th 2024

CagriSema Leads to Weight Reduction of Approximately 23% in Phase 3 REDEFINE 1 Clinical Trial / image credit ©JHVE photo/stock.adobe.com
CagriSema Leads to Weight Reduction of Approximately 23% in Phase 3 REDEFINE 1 Clinical Trial, Short of the 25% Expected

December 20th 2024

FDA approves crinecerfont for congenital adrenal hyperplasia in adult and children in landmark decision
FDA Approves Crinecerfont for Congenital Adrenal Hyperplasia in Adults and Children in Landmark Decision

December 14th 2024

Antiobesity Drugs May Help Curb Alcohol Consumption: Daily Dose / image credit: ©New Africa/AdobeStock
Antiobesity Drugs May Help Curb Alcohol Consumption: Daily Dose

December 12th 2024

Latest CME Events & Activities
<1
...
2627282930
© 2025 MJH Life Sciences

All rights reserved.